P947 is a gadolinium-based magnetic resonance imaging (MRI) contrast agent with high affinity for several matrix metalloproteinases (MMPs) involved in arterial wall remodelling. We tested whether the intensity of enhancement detected in vivo in the arterial wall with P947 and MRI correlates with actual tissue MMP-related enzymatic activity measured in a rabbit atherosclerotic model subjected to dietary manipulations.
Introduction
Acute coronary syndromes and ischaemic strokes are most often caused by the fibrous cap disruption of atherosclerotic plaques. 1 Sudden exposure of the underlying atheromatous content to blood triggers the formation of a thrombus that can occlude the artery or embolize distally leading to myocardial or cerebral necrosis. 2, 3 Identification of atherosclerotic plaques at risk of rupture † F.H. and E.V. contributed equally to the article.
could be useful for risk stratification and early implementation of therapies aimed at plaque stabilization. Matrix metalloproteinases (MMPs) are a broad family of zincdependent endopeptidases, which play a key role in the degradation and remodelling of the extra-cellular matrix network. Previous histological studies demonstrated strong expression of MMPs and in situ matrix-degrading gelatinolytic activity in the fibrous cap of human atherosclerotic plaques, 4 as well as in atherosclerotic lesions that were induced in experimental models. 5 Therefore,
MMPs are thought to play a key role in the pathological remodelling associated with the natural history of the atherosclerotic plaques, from the initial formation of lesions and the outward arterial remodelling to the thinning and weakening of the extra-cellular matrix scaffold forming the fibrous cap favouring plaque rupture. 6 Hence, non-invasive imaging of MMP activity in atherosclerotic plaques represents an attractive approach to monitor changes in the atherosclerotic plaques and identify those prone to rupture. Magnetic resonance imaging (MRI) allows for the discrimination of atherosclerotic plaque components (fibrous cap, lipid core, and haemorrhage) with a high spatial resolution. 7, 8 Using an approach similar to nuclear medicine, contrast agents targeting specific molecules are developed for the detection of biological activities with MRI. This new field known as 'molecular MRI' offers the opportunity to image biological activities with a high spatial resolution.
9
P947 is a novel gadolinium-based MRI contrast agent with a high affinity for several MMPs. Our group has recently demonstrated that P947 accumulates in MMP-rich atherosclerotic plaques of ApoE2/2mice. 10, 11 In a previous work, 12 variations of MMP-related enzymatic activity in atherosclerotic plaques of rabbits subjected to dietary changes were detected ex vivo. In this study, we advanced towards testing the utility of the technique for clinical imaging of atherosclerotic plaques by testing whether (i) such effects can be distinguished in vivo using P947-enhanced MRI, and (ii) the intensity of enhancement detected in the aortic wall with P947 and MRI correlates with actual MMP activity.
Methods
Magnetic resonance imaging contrast agents P947 (Guerbet) was synthesized by binding covalently a broad-spectrum MMP inhibitor 13 formed of four amino acids (Gly-Pro-Leu-Ala) to a gadolinium chelate [gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7 10-tetraacetic acid (DOTA)] at a 1:1 molar ratio with a thiourea function. The MMP inhibitor forming P947 was selected with a micromolar affinity for MMPs to allow for fast clearance of P947 from tissues. P947 has a molecular weight of 1210 Da and an r1 relaxivity of 5.5 mM 21 s 21 at 1.5 T in 378C water. Blood half-life of P947 was measured at 30 min in rabbits. P1135 has the same properties as P947 (identical molecular weight, relaxivity, and blood half-life) except that the sequence of four aminoacids constitutive of the MMP-inhibiting moiety was scrambled. Concentrations of P947, P1135, and a broad-spectrum MMP inhibitor ilomastat (Calbiochem) yielding a 50% inhibition (IC 50 ) of MMP activity in vitro with an MMP inhibitor profiling kit (QuantiZyme Assay system; Biomol International) are displayed in Table 1 .
Animal model
Atherosclerotic plaques were induced in the abdominal aorta of 15 New Zealand white rabbits (mean age: 4 months; mean weight: 3.1 + 0.2 kg, Covance) by a combination of 4 months of an atherogenic diet (4.7% coconut oil and 0.3% cholesterol-enriched diet, Research Diet) and a repeated balloon injury of the aorta (2 weeks and 6 weeks after starting the high-cholesterol diet), as previously described.
14 Rabbits from the 'high-fat' group were fed a lipidsupplemented diet (4.85% coconut oil and 0.15% cholesterol).
Rabbits from the 'low-fat' group were fed a purified chow diet without cholesterol. All experiments were approved by the Mount Sinai School of Medicine Institute Animal Care and Use Committee.
Plasma cholesterol levels
Peripheral blood was collected from the ear vein under local anaesthesia for measurement of plasma cholesterol concentrations by enzymatic assays (Sigma Diagnostics).
Magnetic resonance imaging
General anaesthesia was induced with an intramuscular injection of 20 mg/kg of ketamine (Fort Dodge Animal Health), 10 mg/kg of xylazine (Bayer Corp.,), and 0.5 mg/kg of acepromazine (Fort Dodge Animal Health). A 22-gauge catheter was placed in the marginal ear vein. Rabbits were imaged before injection and at 5, 30, 60, and 90 min after the injection of 50 mmol Gd/kg of P947 or P1135 using a 1.5 T MRI system (Siemens Sonata, Siemens Medical Solutions) with a conventional phased-array knee coil. Care was taken in placing rabbits in identical positions in the coil for the different imaging. Ten sequential, 2 mm thick, axial slices of the aorta were acquired from the celiac trunk to the iliac bifurcation using a fast spin-echo T1-weighted sequence giving an in-plane resolution of 400×400 mm (repetition time: 800 ms; echo time: 5.6 ms; field of view: 10×10 cm; matrix: 256×256; echo train length: 8; signal averages: 4; inter-slice gap: 3 mm). Inferior and superior radiofrequency saturation pulses were added to null the signal from flowing blood in the inferior vena cava and aorta, and spectral fat suppression to null the signal from the peri-adventitial fat.
Study protocol
After 4 months of atherogenic diet, the rabbits (n ¼ 15) underwent a first MRI with injection of P947 ( Figure 1 ). Rabbits were divided by a random drawing into three groups: five atherosclerotic rabbits were sacrificed 1 week after the first MRI to evaluate baseline lesions ('baseline' group); five rabbits continued to be fed a lipid-supplemented diet ('high-fat' group); and five rabbits were switched from atherogenic to a purified chow diet ('low-fat' group). Four months later, rabbits from the 'low-fat' and 'high-fat' groups underwent a second MRI session. Magnetic resonance imaging was performed in rabbits (n ¼ 10) with injection of P947 and, 1 week later, with injection of P1135. 
Image analysis
Magnetic resonance images were analysed with ImagePro Plus (Media Cybernetics). Signal intensities were measured in each rabbit on 10 sequential axial T1-weighted images before, 5, 30, 60, and 90 min after injection of each contrast agent. Origin of the left renal artery and iliac bifurcation was identified on each MRI acquisition and were used to ensure identical slice position between pre-and post-contrast images and between the different MRI performed in the same rabbit.
Regions of interest (ROI) encompassing the aortic wall were drawn manually on the MR acquisition obtained 5 min after the injection of contrast agent. Preliminary work confirmed that ROI of the aortic wall identified on post-contrast acquisitions were close to the ones obtained on T2-weighted acquisitions previously validated for measurements of plaque area. 15 These ROI were then copied on each axial slice of the acquisitions obtained before and at the different time points after the injection of contrast agent. Areas and mean signal intensity of the aortic wall were then measured in these ROIs by an operator (JC.C.) blinded to rabbit group and injected contrast agent. Standard deviation (SD) of noise was measured in a ROI located outside of the rabbit. The following parameters were calculated for each axial slice:
Signal to Noise Ratio (SNR) of aortic wall = SI of aortic wall SD of noise .
Aortic wall enhancement (%) = SNR post-contrast−SNR pre-contrast SNR pre-contrast ×100
Aortic wall area, signal to noise ratio (SNR), and aortic wall enhancement were expressed for each rabbit as the mean value of the 10 sequential axial slices. Aortic wall area and enhancement were measured in all rabbits by a second operator (FH) to evaluate interoperator reproducibility.
Gel electrophoresis zymography of conditioned media
Rabbits were euthanized by an intravenous injection of 120 mg/kg of sodium pentobarbital (Sleepaway, Fort Dodge Animal Health) 1 week after the last MRI. A bolus of heparin was injected prior to euthanasia to prevent clot formation. Abdominal aortas were excised, washed with saline, and cut into ten 5 mm length segments. Three segments were randomly chosen for in situ zymography. The seven remaining segments were first weighted and then incubated for 24 h in 250 mL of serum-free Dulbecco's modified Eagle medium (Biomedia) at 378C in humidified 5% CO 2 /95% air. Gelatinolytic activities of conditioned media were measured as previously described. 16 Pro-forms of MMPs undergo a conformational change in the presence of sodium dodecyl sulfate revealing their catalytic site, which allows for their detection with zymography. Densitometric analysis of scanned gelatinolytic bands was performed with Quantity One software (Bio-Rad). Results are expressed as mean densitometric units per milligram wet weight.
In situ gelatine zymography
Aortic segments chosen for in situ zymography were snap frozen with Optimal Cutting Temperature compound in isopentane pre-chilled with liquid nitrogen and sectioned in serial 8 mm thick slices. For optimal matching with MRI slices, the location of each segment along the aorta was defined by measuring the distance between the segment and the origin of the left renal artery or the iliac bifurcation. In situ gelatine zymographies were performed using the quenched substrate dye-quenched (DQ)-gelatine (Invitrogen), which becomes fluorescent after cleavage by MMPs. Reagent solution was obtained by dissolving at a 1:1 ratio DQ-gelatine at a concentration of 0.5 g/L with 1% agarose. 17 Cryosections of atherosclerotic plaques were covered with 50 mL of the solution using a coverslip. Figure 1 Study design. Atherosclerotic plaques were induced in 15 New Zealand White rabbits by a combination of an atherogenic diet and repeated endothelial abrasion of the aorta 4 weeks apart (black arrows). After 4 months of atherogenic diet, a first magnetic resonance imaging (MRI; white arrow) was performed at baseline in all the rabbits after injection of the matrix metalloproteinases-specific contrast agent P947. After this first magnetic resonance imaging, five rabbits were sacrificed and formed the 'baseline' group. The 10 remaining rabbits were split into two groups: five rabbits were left on the hyperlipidaemic diet and composed the 'high-fat' group; and five rabbits were switched to a chow diet and formed the 'low-fat' group. Four months later, the 10 remaining animals were imaged with magnetic resonance imaging, first, after injection of the matrix metalloproteinases-specific contrast agent P947 and, 1 week later, after injection of the non-specific contrast agent P1135 (white arrows).
After 24 h incubation, the fluorescence signal of DQ-gelatine was captured using a confocal laser microscope (excitation wavelength: 488 nm, emission wavelength: 505 -560 nm, Zeiss LSM 510 META microscope). In addition, adjacent cryosections were fixed in paraformaldehyde and coloured with combined Masson's elastin staining. For inhibition studies, reagent solution was brought to a 200 mM concentration of P947 or P1135 in reaction buffer (0.5 M Tris HCl, 1.5 M NaCl, 50.0 mM CaCl 2 , 2.0 mM sodium azide, pH 7.6). As control for inhibition studies, initial reagent solution underwent a similar dilution with reaction buffer. As control for auto-fluorescence, cryosections were incubated in the same conditions with a solution lacking DQ-gelatine.
Statistics
All probabilities were two-sided and expressed as mean + SD. Values of P , 0.05 were considered as statistically significant. Statistical analysis was conducted with SPSS software (SPSS Inc.,). Differences in weights, cholesterol levels, aortic wall areas, and aortic wall enhancements were tested in three-independent groups using a nonparametric Kruskall -Wallis test, in two-independent groups using a non-parametric Mann-Whitney test and in two non-independent groups using a non-parametric Wilcoxon signed-ranked test. Kinetics of aortic wall enhancement after injection of P947 and P1135 were compared using a two-way ANOVA test for multiple time points and a post-hoc Bonferroni test. Differences in MMP activities between the three groups of rabbits were tested using a one-way ANOVA test and a post-hoc Bonferroni t-test. Correlations were calculated with a Pearson test.
Results

Rabbit weights and cholesterol levels
At baseline, mean weights and plasma cholesterol were similar between the three groups of rabbits ('baseline', 3.6 + 0.2 kg, 410 + 90 mg/100 dL; 'high-fat', 3.7 + 0.3 kg, 420 + 100 mg/ 100 dL; 'low-fat', 3.5 + 0.2 kg, 400 + 60 mg/100 dL, respectively; P ¼ 0.25 for rabbit weight and P ¼ 0.61 for plasma cholesterol). Four months later, plasma cholesterol was significantly lower in rabbits from the 'low-fat' group compared with rabbits from the 'high-fat' group (60 + 30 vs. 360 + 160 mg/100 dL; P ¼ 0.04), whereas mean rabbit weights were identical in both groups (3.6 + 0.4 kg).
Magnetic resonance imaging of the arterial wall
On the first MRI, aortic wall areas measured 5 min after injection of P947 were similar in the three groups of rabbits ('baseline', 8.6 + 0.5 mm 2 ; 'high-fat', 8.4 + 0.3 mm 2 ; 'low-fat', 8.5 + 0.4 mm 2 ; P ¼ 0.89). Ninety minutes after the injection of P947, a strong enhancement was detected in the aortic wall (Figure 2 ), but was not significantly different between the three groups of rabbits ( Figure 3A ; 'baseline', 52 + 5%; 'high-fat', 47 + 5%; 'low-fat', 47 + 10%; P ¼ 0.47).
Four months later, aortic wall area increased in rabbits from the 'high-fat' group which pursued the high-cholesterol diet (9.5 + 1.3 vs. 8.4 + 0.3 mm 2 ; P ¼ 0.22) and decreased in rabbits from the 'low-fat' group, which were switched to a chow diet (7.8 + 0.5 vs. 8.5 + 0.4 mm 2 ; P ¼ 0.14). Ninety minutes after the injection of P947, aortic wall enhancement of rabbits from the 'low-fat' group was significantly lower (Figures 2 and 3B) as compared with (i) the first MRI acquired in same rabbits 4 months earlier (21 + 6 vs. 47 + 10%, respectively; P ¼ 0.04) and (ii) the second MRI performed in rabbits from the 'high-fat' group given the hyperlipidaemic diet (21 + 6 vs. 46 + 3%, respectively; P ¼ 0.04). Aortic wall enhancement of rabbits from the 'high-fat' group was not significantly different between the first and second MRI (47 + 5 vs. 46 + 3%; P ¼ 0.59). Inter-operator reproducibility of aortic wall enhancement after injection of P947 per rabbit was excellent (r ¼ 0.97). In contrast to results achieved with P947, no significant difference in aortic wall enhancement was detected between 'low-fat' and 'high-fat' groups of rabbits when MRI was performed after injection of P1135, the scrambled version of P947 (22 + 3 vs. 21 + 2%, respectively; P ¼ 0.89).
To evaluate the proportion of aortic wall enhancement that can be attributed to a specific binding of P947 to MMPs, kinetics of P947 and P1135 were compared between 'low-fat' and 'high-fat' groups of rabbits. Five minutes after the injection of either P947 or P1135, a diffuse enhancement was present in the aortic wall ( Figure 4A ). Aortic wall areas defined at this time point were similar after injection of P947 or P1135 in the 'high-fat' group (9.5 + 1. In rabbits from the 'high-fat' group, kinetics of aortic wall enhancement was significantly different after injection of P947 or P1135 ( Figure 4B ; P947 vs. P1135, P , 0.001). Signal to noise ratios of the aortic wall was higher at 5 min after injection of P947 than after injection of P1135 and decreased slower at later time points (P , 0.001 for all time points), in favour of a specific retention of P947 in the aortic wall. In contrast, kinetics of aortic wall enhancement in rabbits from the 'low-fat' group were similar after injection of each contrast agent (P947 vs. P1135, P ¼ 0.76).
Matrix metalloproteinases-related gelatinolytic activity in atherosclerotic plaques
In situ zymography performed on arterial tissue cryosections showed intense gelatinolytic activities in the intima and adventitia of atherosclerotic plaques of rabbits from the 'high-fat' group, whereas only weak gelatinolytic activity was detected in plaques of rabbits from the 'low-fat' group ( Figure 5) . Strong enhancement in the aortic wall with MRI 90 min after the injection of P947 was associated with the presence of intense gelatinolytic activity with in situ zymography on corresponding cryosections of atherosclerotic plaques.
In situ zymography tests were repeated on adjacent cryosections of atherosclerotic plaques from the 'high-fat' group after adding P947, P1135, or reaction buffer to the substrate solution ( Figure 6 ). P947 but not P1135 inhibited gelatinolytic activities in atherosclerotic plaques. No fluorescence was present on cryosections incubated with a solution lacking the DQ-gelatine. Independent experiments with five different aortic segments yielded similar results.
In addition, samples of culture media of aortic segments were run on gelatine zymography gels. Intense pro-MMP-9 (98 kDa), pro-MMP-2 (70 kDa), and active MMP-2 (60 kDa) gelatinolytic bands were detected in the conditioned media of atherosclerotic plaques ( Figure 7A ). Lower MMP-2 activities were measured in Figure 2 Monitoring of arterial wall remodelling with P947-enhanced magnetic resonance imaging (MRI). Representative axial views of aortic walls imaged at baseline and 4 months later in a rabbit from the 'low-fat' group (left panels) and the 'high-fat' group (right panels) with P947-enhanced magnetic resonance imaging. At baseline, note the strong enhancement detected with magnetic resonance imaging after the injection of P947 in the aortic wall of both rabbits. Four months later, the enhancement detected in the aortic wall of the rabbit from the 'low-fat' group, which had been switched to a chow diet, strongly decreased after injection of P947. In contrast, the enhancement detected in the rabbit from the 'high-fat' group, which pursued a hyperlipidaemic diet, was strong and similar to the first magnetic resonance imaging. Inserts are magnifications of aortas. White arrowheads denote the rabbit aorta. Bar width, 10 mm.
Monitoring of arterial wall remodelling the conditioned media of atherosclerotic plaques from the 'low-fat' group as compared with 'baseline' and 'high-fat' groups ( Figure 7B ; 737 + 194 vs. 1718 + 193 and 1472 + 267 densitometric units per milligram wet weight, respectively; P , 0.001). Pro-MMP-2 activities did not differ significantly in aortic segments from the three groups of rabbits ('baseline', 4336 + 654; 'high-fat', 4124 + 1132; 'low-fat', 3153 + 414; P ¼ 0.09).
Matrix metalloproteinases activities measured in the incubation media of aortic segments were then compared with the enhancement measured in the aortic wall 90 min after injection of P947 with the MRI performed in the former 2 weeks in each rabbit (n ¼ 15). A stronger correlation ( Figure 7C ) was observed between aortic wall enhancement with P947-enhanced MRI and MMP-2 activity than with pro-MMP-2 activity (r ¼ 0.87; r ¼ 0.28, respectively).
Discussion
In the present study, we showed that the intensity of enhancement 90 min after the injection of P947 significantly decreased in the aortic wall 4 months after switching rabbits from a hyperlipidaemic to a chow diet, whereas the intensity of enhancement remained high in the aortic wall of rabbits maintained on a hyperlipidaemic diet. Such changes were not detected with the contrast agent P1135, which lacks the MMP-specific peptide sequence. In addition, we found a strong correlation between the intensity of enhancement in the aortic wall with MRI 90 min after the injection of P947 and MMP-related enzymatic activity measured ex vivo with gelatine zymography in corresponding atherosclerotic plaques. These results demonstrate that P947 and a clinical MRI scanner can be used to distinguish non-invasively the effects of dietary manipulations upon variations of tissue MMP enzymatic activity within atherosclerotic plaques.
Specificity of P947 for matrix metalloproteinases
Specificity of P947 for MMPs present in atherosclerotic plaques has been tested using several strategies. First, a competition study was performed ex vivo in atherosclerotic aortic segments of rabbits and confirmed a significantly lower enhancement measured with MRI when the aortic segments had been pre-incubated with the free peptide forming P947. 10 This approach could, however, not be translated in vivo because of the low water solubility of the peptide. Second, a fluorescent form of P947 was synthesized by replacing the gadolinium by a europium molecule in the chelate and was injected in vivo in Apo E2/2mice. The fluorescent form of P947 accumulated in MMP-rich areas of atherosclerotic plaques identified by immunohistology. 11 Synthesis of fluorescent P947 had a very low yield and did not provide sufficient concentrations for in vivo injection in rabbits. In this study, the specificity of P947 for MMPs was, therefore, tested by comparing the enhancement obtained in the aortic wall of the same rabbits after injection of the contrast agents P947 and P1135 that have the same properties as P947 except that the sequence of four aminoacids constitutive of the MMP-inhibiting moiety was scrambled.
A significantly higher retention of contrast agent was detected no significant difference in aortic wall enhancement was measured between 'baseline', 'high-fat', and 'low-fat' groups after injection of the matrix metalloproteinases-specific contrast agent P947. Four months later, the enhancement detected in the aortic wall with P947-enhanced magnetic resonance imaging was significantly lower in rabbits from the 'low-fat' group, which had been switched to a chow diet, as compared with the same rabbits 4 months earlier, and to rabbits from the 'high-fat' group which pursued a hyperlipidaemic diet. No significant difference in aortic wall enhancement could be detected between 'high-fat' and 'low-fat' groups after injection of the non-specific contrast agent P1135. *P , 0.05. (B) Changes in aortic wall enhancement 90 min after injection of P947 between the first and second magnetic resonance imaging in each rabbit from the 'high-fat' and 'low-fat' groups.
after injection of P947 as compared with P1135 in the aortic wall of rabbits from the 'high-fat' group, which contained high gelatinolytic activities. In contrast, kinetics of aortic wall enhancement was similar after injection of P947 or P1135 in rabbits from the 'low-fat' group, which contained low MMP activities. In addition, a strong correlation was found between the intensity of aortic wall enhancement after injection of P947 and the MMP-related enzymatic activity measured in corresponding aortic segments. Taken together, these results pledge for a specific retention of P947 in MMP-rich aortic wall of rabbits.
Choice of imaging time point
The contrast agents evaluated in this study were of low molecular weight and were expected to be rapidly cleared out of atherosclerotic plaques in case of non-specific accumulation. In fact, a relatively slow wash out of atherosclerotic plaques was detected after injection of P1135 and could be related to the presence of a gadolinium chelate, which is known to accumulate in atherosclerotic plaques. 18 Kinetics studies showed a faster decrease of aortic wall enhancement after injection of P1135 as compared with P947. The 90 min imaging time point after injection of P947 seemed optimal to detect the specific retention of P947 in the aortic wall with a relatively low non-specific background enhancement and was, therefore, chosen as an endpoint in this study.
Imaging of adventitial matrix metalloproteinases activity
In this study, the enhancement detected in the arterial wall with MRI 90 min after the injection of P947 was heterogeneous but predominated in areas close to the lumen and in the outer region of Figure 4 Kinetics of aortic wall enhancement after injection of P947 or P1135. (A) Note the strong and diffuse enhancement 5 min after injection of P947 or P1135 in the aortic wall of rabbits from both 'high-fat' and 'low-fat' groups detected with magnetic resonance imaging. Aortic wall areas were, therefore, drawn manually at this imaging time point (right inserts, regions of interest in grey). At later time points, the intensity of enhancement decreased faster in the aortic wall of rabbits from 'high-fat' group after injection of P1135 and from 'low-fat' group after injection of P947 as compared with rabbits from 'high-fat' group after injection of P947. Bar width, 10 mm. (B) Kinetics of aortic wall enhancement in rabbits from 'high-fat' and 'low-fat' groups after injection of P947 or P1135 with the second magnetic resonance imaging. In rabbits from the 'high-fat' group, signal to noise ratio (SNR) of the aortic wall decreased at a slower rate after injection of P947 than after P1135. No such difference could be detected in rabbits from the 'low-fat' group. *P , 0.05. the aortic wall. In situ zymography confirmed the presence of gelatinolytic activities both in the fibrous cap close to the lumen and in the adventitia of corresponding aortic sections. Matrix metalloproteinases activities were measured in aortic segments that contained the adventitia. Therefore, the ROI drawn to measure aortic wall enhancement included also the outer area of the aortic wall. In fact, MMP activity in the adventitia could play a key role in positive remodelling of atherosclerotic plaques (i.e. development of plaques outwards) and reflect atherosclerotic plaque content. Positive remodelling of atherosclerotic plaques could initially be beneficial by preserving the lumen 19 but was also often found with intravascular ultrasound 20 and computed tomography 21 in ruptured coronary atherosclerotic plaques of patients presenting with acute coronary syndromes. Interestingly, coronary atherosclerotic plaques with an outward remodelling contained higher MMP activities in the adventitia than those with a constrictive remodelling. 22 Indeed, positive/outward remodelling was reported to characterize vulnerable plaques, 23 and had been previously associated with other markers of plaque instability such as rich inflammatory infiltrate, and decreased collagen and smooth muscle cells in the caps and shoulders of atherosclerotic plaques. 24 In fact, detecting MMP-rich areas with P947-enhanced MRI may be easier in the adventitia than in the thin fibrous cap of high-risk atherosclerotic plaques and could represent an additional non-invasive marker of plaque instability.
Early detection of aortic wall remodelling
Matrix metalloproteinases have been strongly involved in plaque remodelling and stabilization of plaques. 5 In a previous study performed in the same rabbit model of atherosclerosis, 15 lipid lowering by diet was followed 7 months later by a regression of atherosclerosis burden with a decrease in lipid component, an increase in the fibrosis component, and negative remodelling of plaques. Indeed, reduced MMP activity in atherosclerotic plaques 16 months after switching rabbits from a hyperlipidaemic to a chow diet suggests that a decreased catabolism contributes to arterial collagen accumulation. 12 In our study, a similar trend towards a regression of plaque burden was found 4 months Figure 2 . Intense gelatinolytic activities (green fluorescence, white arrowheads) were detected in the fibrous cap and adventia of atherosclerotic plaques from rabbits of the 'high-fat' group, whereas only weak fluorescence was detected in atherosclerotic plaques from rabbits of the 'low-fat' group. Images of in situ zymographies were acquired using a confocal laser microscope with identical amplification gain settings. *, lumen. Bar width, 500 mm.
after switching rabbits from high cholesterol to a chow diet. In addition, a strong decrease of MMP gelatinolytic activity was detected in atherosclerotic plaques by both P947-enhanced MRI (in vivo) and ex vivo zymography as soon as 4 months after the change of diet. These results suggest that decreased gelatinolytic activity in atherosclerotic plaques after lowering plasma lipids could represent an early marker of the evolution of plaques towards stabilization.
Place of molecular magnetic resonance imaging for detection of matrix metalloproteinases activity in the arterial wall
In previous works, 25 -27 detection of MMP activity in the arterial wall of atherosclerotic mice was demonstrated using optical and nuclear imaging techniques. These techniques have, however, important limitations for the clinical evaluation of atherosclerotic plaques in humans. Optical imaging remains restricted to the evaluation of superficial structures or small animals because of light scattering caused by overlaying tissues; and nuclear imaging has a high sensitivity for the detection of radiotracers but is limited by a spatial resolution of a few millimetres and the absence of anatomical images. 28 In contrast, some important features of atherosclerotic plaques (e.g. thin fibrous cap, large necrotic core, or haemorrhage) can be identified in patients using MRI through their different intrinsic relaxation properties. 7, 8 In addition to high spatial resolution imaging, detection of biological activities using contrast agents targeting specific molecules involved in plaque destabilization would strongly improve the potential of MRI to identify plaques prone to rupture and monitor the effect of therapeutic or dietary interventions.
Study limitations
The interpretation of this study must consider several limitations. First, a relatively small number of animals were studied. One hurdle with low molecular weight MRI contrast agents is that they require micromolecular concentrations to be detected with MRI. 28 At this stage of development of the contrast agent, synthesis of P947 was complex, and therefore, only a limited number of rabbits could be imaged. Second, competitive blocking of P947 with a version of P947 lacking gadolinium was not evaluated in this study. Nevertheless, regarding the high number of binding sites for MMP and the micromolar affinity of P947 for MMP, competition studies would have required high concentrations of P947 lacking gadolinium to test this approach in rabbits, which were not available at this stage of development of the contrast agent.
In addition, lack of gadolinium in the chelate can modify the electric charge of the molecule and change pharmacokinetics and properties of the contrast agent. Third, a first acquisition needs to be performed prior to contrast administration. Finally, the results obtained in an experimental model of atherosclerosis need to be validated in complex human atherosclerotic plaques. In a former study, 10 a higher retention of P947 in human carotid endarteriectomies was, however, evidenced by ex vivo MRI in MMP rich as compared with MMP-poor atherosclerotic plaques. , and matrix metalloproteinases-2 (60 kDa) gelatinolytic activities in conditioned media of aortic segments from the three groups of rabbits. Matrix metalloproteinases-2 gelatinolytic band was weaker in aortic segments from the 'low-fat' group as compared with aortic segments from 'baseline' and 'high-fat' groups. (B) Significantly lower matrix metalloproteinases-2 activities were measured in conditioned media of the 'low-fat' as compared with either 'baseline' or 'high-fat' groups. Pro-matrix metalloproteinases-2 activities did not differ significantly in aortic segments from the three groups of rabbits. (C) Mean gelatinolytic activities measured in incubation media of aortic segments of each rabbit (n ¼ 15) were compared with the enhancement measured in the aortic wall after injection of P947 with the magnetic resonance imaging performed in the former 2 weeks in corresponding animals. A strong correlation was observed between P947-enhanced magnetic resonance imaging and matrix metalloproteinases-2 activity, whereas correlation was weaker with pro-matrix metalloproteinases-2 activity. DU, densitometric units; *P , 0.05.
Perspectives
In summary, we demonstrate in the present study that P947-enhanced MRI distinguishes variations of MMP-related enzymatic activity within plaques as an effect of dietary changes in an experimental model of atherosclerosis. Translation of this imaging technology to the clinical field could give deeper insights into the role of MMPs in arterial wall remodelling in vivo and a clinical modality to image and monitor markers previously associated with plaque progression and instability. Thus, in association with morphological aspects of atherosclerotic plaques identified with MRI, P947 may help to identify patients with plaques prone to rupture who could benefit from early implementation of therapies aimed towards plaque stabilization.
